Sequencing of PD-1/L1 Inhibitors and Carboplatin-Based Chemotherapy for Cisplatin-Ineligible Metastatic Urothelial Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Sequencing of PD-1/L1 Inhibitors and Carboplatin-Based Chemotherapy for Cisplatin-Ineligible Metastatic Urothelial Carcinoma
J Urol 2020 Sep 16;[EPub Ahead of Print], XX Wei, L Werner, MY Teo, JE Rosenberg, VS Koshkin, P Grivas, B Szabados, L Morrison, T Powles, L Carril-Ajuria, D Castellano, PI Velho, NM Hahn, RR McKay, D Raggi, A Necchi, R Kanesvaran, P Alerasool, J Gaines, M Galsky, J Bellmunt, G SonpavdeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.